Who owns Intercept Pharmaceuticals In Note 2.000 5/1 bnd?
- CUSIP Number: 45845pab4
Tip: Access positions for across all investors
Analyze quarterly positions in Intercept Pharmaceuticals In Note 2.000 5/1 bnd with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Intercept Pharmaceuticals In Note 2.000 5/1 bnd stock
Who bought or sold Intercept Pharmaceuticals In Note 2.000 5/1 bnd this quarter?
There are no current stakeholders of Intercept Pharmaceuticals In Note 2.000 5/1 bnd.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Intercept Pharmaceuticals In Note 2.000 5/1 bnd?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ubs Global Asset Management Americas | Dec 2023 | 3.0M | $3.0M |